0.2194
price up icon7.02%   0.0144
after-market Dopo l'orario di chiusura: .21 -0.0094 -4.28%
loading

Syros Pharmaceuticals Inc Azioni (SYRS) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
100.00%
-
0.386 3.762 2.833 2.954
Operating Expenses
12.33%
30.92
27.53 38.40 36.83 36.17
Interest Income/Expense
1.66%
1.307
1.329 1.303 1.278 1.217
Operating Income/Loss
13.93%
-30.92
-27.14 -34.64 -34.00 -33.21
Income/Loss From Continuing Operations Before Tax
103.37%
-3.708
110.13 3.762 2.833 -23.79
Income/Loss From Continuing Operations After Tax
94.24%
-3.708
-64.38 -40.14 -36.26 -23.79
Net Income/Loss
94.24%
-3.708
-64.38 -40.14 -36.26 -23.79
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
9,411%
38.98
0.4098 27.99 27.91 27.84
Diluted Average Shares
9,411%
38.98
0.4098 27.99 27.91 27.84
Basic Earnings Per Share
95.50%
-0.10
-2.22 -1.43 -1.30 -0.85
Diluted Earnings Per Share
95.50%
-0.10
-2.22 -1.43 -1.30 -0.85
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$30.75
price down icon 0.65%
$71.93
price down icon 0.75%
$19.03
price up icon 4.62%
$358.93
price down icon 2.04%
biotechnology ONC
$210.08
price up icon 2.31%
$111.93
price down icon 0.74%
Capitalizzazione:     |  Volume (24 ore):